Home

caps nlrp3

NLRP3 - Ventus Therapeutics
NLRP3 - Ventus Therapeutics

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic  candidates for inflammatory diseases (Review)
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)

JCI - Confounding role of tumor necrosis factor in cryopyrin-associated  periodic syndromes
JCI - Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes

PKD-mediated NLRP3 activation pathway and the relevant CAPS mutations.... |  Download Scientific Diagram
PKD-mediated NLRP3 activation pathway and the relevant CAPS mutations.... | Download Scientific Diagram

The NLRP3 inflammasome: regulation by metabolic signals: Trends in  Immunology
The NLRP3 inflammasome: regulation by metabolic signals: Trends in Immunology

Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich–Containing Family,  Pyrin Domain–Containing-3) Inflammasome in Cardiovascular Disorders |  Arteriosclerosis, Thrombosis, and Vascular Biology
Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich–Containing Family, Pyrin Domain–Containing-3) Inflammasome in Cardiovascular Disorders | Arteriosclerosis, Thrombosis, and Vascular Biology

The NLRP3 inflammasome: contributions to inflammation-related diseases |  Cellular & Molecular Biology Letters | Full Text
The NLRP3 inflammasome: contributions to inflammation-related diseases | Cellular & Molecular Biology Letters | Full Text

Cells | Free Full-Text | Specific NLRP3 Inflammasome Assembling and  Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases
Cells | Free Full-Text | Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases

Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory  bowel disease - ScienceDirect
Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease - ScienceDirect

NLRP3 Inflammasome as a Therapeutic Target for Atherosclerosis: A Focus on  Potassium Outflow
NLRP3 Inflammasome as a Therapeutic Target for Atherosclerosis: A Focus on Potassium Outflow

The NLRP3/NEK7 complex domains and related CAPS mutations. A 3D cartoon...  | Download Scientific Diagram
The NLRP3/NEK7 complex domains and related CAPS mutations. A 3D cartoon... | Download Scientific Diagram

Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular  Activation, and Inhibitor-NLRP3 Interaction | Pharmacological Reviews
Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction | Pharmacological Reviews

The NLRP3 inhibitor MCC950 inhibits... | Wellcome Open Research
The NLRP3 inhibitor MCC950 inhibits... | Wellcome Open Research

T helper 1 immunity requires complement-driven NLRP3 inflammasome activity  in CD4+ T cells | Science
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells | Science

The NLRP3 inflammasome: molecular activation and regulation to therapeutics  | Nature Reviews Immunology
The NLRP3 inflammasome: molecular activation and regulation to therapeutics | Nature Reviews Immunology

CAPS and NLRP3 | SpringerLink
CAPS and NLRP3 | SpringerLink

CAPS and NLRP3 | SpringerLink
CAPS and NLRP3 | SpringerLink

An update on the regulatory mechanisms of NLRP3 inflammasome activation |  Cellular & Molecular Immunology
An update on the regulatory mechanisms of NLRP3 inflammasome activation | Cellular & Molecular Immunology

Targeting the NLRP3 inflammasome in inflammatory diseases | Nature Reviews  Drug Discovery
Targeting the NLRP3 inflammasome in inflammatory diseases | Nature Reviews Drug Discovery

Frontiers | Pharmacological Inhibitors of the NLRP3 Inflammasome
Frontiers | Pharmacological Inhibitors of the NLRP3 Inflammasome

Biomedicines | Free Full-Text | Anti-NLRP3 Inflammasome Natural Compounds:  An Update
Biomedicines | Free Full-Text | Anti-NLRP3 Inflammasome Natural Compounds: An Update

NLRP3 leucine-rich repeats control induced and spontaneous inflammasome  activation in cryopyrin-associated periodic syndrome - Journal of Allergy  and Clinical Immunology
NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome - Journal of Allergy and Clinical Immunology

MCC950 | NLRP3 inflammasome inhibitor | InvivoGen
MCC950 | NLRP3 inflammasome inhibitor | InvivoGen

Frontiers | Regulation of the NLRP3 Inflammasome by Post-Translational  Modifications and Small Molecules
Frontiers | Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules

Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3  Interaction and Exert Anti-inflammatory Activity | Journal of Medicinal  Chemistry
Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity | Journal of Medicinal Chemistry

Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in  cryopyrin-associated periodic syndrome | eLife
Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome | eLife

Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated  inflammatory diseases | Science Immunology
Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases | Science Immunology